Exploring Using Next Generation Sequencing To Identify Biomarkers In Cml
Let's dive into the details surrounding Using Next Generation Sequencing To Identify Biomarkers In Cml.
- Andrew Wu, BS, MS, British Columbia Cancer Agency, Vancouver, Canada, comments on the
- He highlights how
- Dr. Martin Spahn presented “
- Platinum Vendor Showcase: Boston Gene Developing
- Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, Italy, discusses the ...
In-Depth Information on Using Next Generation Sequencing To Identify Biomarkers In Cml
Most patients Join Fight CRC in a webinar about Kinase domain mutations in the BCR-ABL1 gene are associated Hugues de Lavallade, MD, PhD, King's College London, London, UK, discusses the PETALs trial (EudraCT 2013-004974-82).
Lars Bullinger, MD, from the University Hospital of Ulm, Ulm, Germany talks to us about the
That wraps up our extensive overview of Using Next Generation Sequencing To Identify Biomarkers In Cml.